Study identifier:D8221R00003
ClinicalTrials.gov identifier:NCT05999877
EudraCT identifier:N/A
CTIS identifier:N/A
Non-interventional cohort study of patients Previously untreated or first-generation BTKi Intolerant with Chronic lymphocytic leukemia describing the first-line use of Acalabrutinib and its Real-world Outcomes in Spain: the PICAROS study
Chronic Lymphocytic Leukemia
N/A
No
-
All
192
Observational
18 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Dec 2024 by AstraZeneca
AstraZeneca
None
No locations available
Arms | Assigned Interventions |
---|